Business headlines from the Apex backend, organized by sectors and major public companies for faster market scanning.
The retailer plans to extend its free insurance drug benefit to more than 250 prescription medications for certain employees, adding coverage for a class of diabetes and weight-loss drugs known as GLP-1s.
THE APEX TIMES
THE APEX TIMES
Bank of America’s BAC stock was weaker in pre-market trading after the company reported third-quarter earnings per share that did not meet the consensus forecast, a move traders said reflected investor sensitivity to earnings momentum.
THE APEX TIMES
A new comparison of the two technology stocks highlights a stark gap in valuation multiples, with Salesforce trading at a much lower forward earnings multiple than Palantir while generating sizable free cash flow.
THE APEX TIMES
A recent market note urged Intel shareholders to mark Oct. 29, pointing to expectations for solid third-quarter performance supported by demand for computing infrastructure and improving pricing.
THE APEX TIMES
The venture, centered on CenterWell clinics, is bringing $2.8 billion in new capital linked to BlackRock, according to a report published Thursday.
THE APEX TIMES
A fresh round of attention on SpaceX’s planned Starlink mobile expansion, including use of 800 MHz spectrum, is fueling new debate about how much traditional telecom networks can protect pricing and subscriber growth. Comcast, whose stock has drawn an argument for upside, is now caught in that crosscurrent.
THE APEX TIMES
A new Berkshire Hathaway investment in Italian app developer Bending Spoons, reported as a $930 million deal, challenges the conglomerate’s longtime reputation for buying cheaper, cash-generative value stocks. What the purchase does and does not reveal underscores how quickly Berkshire’s portfolio mix can shift.
THE APEX TIMES
A new $300 million move into the Italian software and apps maker underscores Berkshire Hathaway’s continued tilt toward technology, with tech described as its largest holding.
THE APEX TIMES
In comments reported by Yahoo Finance, Elon Musk endorsed Micron Technology’s long-term approach to memory chips, even as Micron’s stock moved lower after the remarks.
